<p><b>TABLE OF INTERACTIONS WITH</b></p>

<p><b> BETA-BLOCKING AGENTS (EXCEPT ESMOLOL) </b></p>

<p><b>From the French ANSM drug interactions document of September 2016, pp. 41-42</b></p>

<table cellspacing="0" cellpadding="0" border="1">
<tbody>
<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>HALOGENATED HYDROCARBON ANESTHETICS</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>N01AB0-001</b></p></td>
<td valign="top"><p>Reduction of the compensatory cardiovascular reactions by the beta-blocking agents. The beta-adrenergic inhibition can be elevated during the surgical procedure by the beta-mimetics</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>As a general rule, do not stop the treatment with the beta-blocking agent and, in any case, avoid stopping it abruptly. Inform the anesthesiologist of this treatment.</p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>CENTRAL ANTIHYPERTENSIVES</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C02AC-001</b></p></td>
<td valign="top"><p>Large increase of blood pressure in cases of sudden discontinuation of the treatment with the central hypertensive</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Avoid stopping the treatment with the central antihypertensive abruptly. Clinical monitoring</p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>NON STEROIDAL ANTI-INFLAMMATORY DRUGS</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>M01A-002</b></p></td>
<td valign="top"><p>Reduction of the antihypertensive effect (inhibition of the vasodilator prostaglandins by the non steroidal anti-inflammatories)</p></td>
<td valign="top"><p><b>Take into account</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>DIHYDROPYRIDINES</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C08CA-002</b></p></td>
<td valign="top"><p>Hypotension, heart failure in patients with latent or uncontrolled cardiac insufficiency (addition of the negative inotropic effects). The beta-blocking agent can furthermore minimize the sympathetic reflex reaction brought into play in the case of excessive hemodynamic repercussion </p></td>
<td valign="top"><p><b>Take into account</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>DILTIAZEM</b></p>

<p><b>RxNorm: 3443</b></p>

<p><b>ATC: C08DB01</b></p></td>
<td valign="top"><p>Disorders of autoregulation (excessive bradycardia, sinus arrest), disorders of sinoatrial and atrioventricular conduction, and heart failure</p></td>
<td valign="top"><p><b>Not recommended</b></p>

<p>The administration of these medications together should only be done under clinical monitoring and strict EKG, in particular with older patients or at the beginning of treatment<b>.</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>DIPYRIDAMOLE</b></p>

<p><b>RxNorm: 3521</b></p>

<p><b>ATC: B01AC07</b></p></td>
<td valign="top"><p>With the dipyridamole by injection: increase of the antihypertensive effect</p>

</td>
<td valign="top"><p><b>Take into account </b></p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>GLINIDES</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>A10BX-001</b></p></td>
<td valign="top"><p>All the beta-blocking agents can mask certain symptoms of hypoglycemia: palpitations and tachycardia</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Inform the patient, and, especially at the beginning of treatment, reinforce self-monitoring of blood glucose</p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>GLIPTINS</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>A10B-001</b></p></td>
<td valign="top"><p>All the beta-blocking agents can mask certain symptoms of hypoglycemia: palpitations and tachycardia</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Inform the patient and, especially at the beginning of treatment, reinforce self-monitoring of blood glucose</p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>INSULIN </b></p>

<p><b> </b></p>

<p><b>RxNorm: 5856 </b></p>

<p><b>ATC:</b></p>

<p><b>A10AC01 A10AC02 A10AC03 A10AC04 A10AD01 A10AD02 A10AD03 A10AD04 A10AD05 A10AE01 A10AE02 A10AE03 A10AE04 A10AE05 A10AF01</b></p></td>
<td valign="top"><p>All the beta-blocking agents can mask certain symptoms of hypoglycemia: palpitations and tachycardia</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Inform the patient and, especially at the beginning of treatment, reinforce self-monitoring of blood glucose.</p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>LIDOCAINE</b></p>

<p><b>RxNorm: 6387</b></p>

<p><b>ATC:</b></p>

<p><b>C01BB01 C05AD01 D04AB01 N01BB02 R02AD02 S01HA07 S02DA01 N01BB52</b></p></td>
<td valign="top"><p>With lidocaine administered by IV route: increase of the plasma concentrations of lidocaine with possibility of undesirable neurological and cardiac effects (decrease of the hepatic clearance of the lidocaine)</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring, EKG, and, possibly testing of the plasma concentrations of lidocaine during the administration of the substances together and after the beta-blocking agent is stopped. Adjustment, if needed, of the dosage of the lidocaine</p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>PROPAFENONE</b></p>

<p><b>RxNorm: 8754 </b></p>

<p><b>ATC: C01BC03</b></p></td>
<td valign="top"><p>Disorders of contractility, autoregulation, and conduction (suppression of the compensatory sympathetic mechanisms)</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring and EKG<b>.</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>BLOOD GLUCOSE LOWERING SULFONAMIDES</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>A10BB</b></p></td>
<td valign="top"><p>All the beta-blocking agents can mask certain symptoms of hypoglycemia: palpitations and tachycardia</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Inform the patient and reinforce self-monitoring of blood glucose, especially at the beginning of treatment<b>. </b></p></td>
</tr>

<tr>
<td valign="top"><p><b>BETA BLOCKING AGENTS (EXCEPT ESMOLOL)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>C07AB-002</b></p></td>
<td valign="top"><p><b>VERAPAMIL</b></p>

<p><b>RxNorm: 11170 </b></p>

<p><b>ATC: C08DA01 </b></p></td>
<td valign="top"><p>Disorders of autoregulation (excessive bradycardia, sinus arrest), disorders of sinoatrial and atrioventricular conduction, and heart failure</p></td>
<td valign="top"><p><b>Not recommended</b></p>

<p>The administration of these medications together should only be undertaken under strict clinical monitoring and EKG, in particular with older patients or at the beginning of treatment. </p></td>
</tr>

</tbody>
</table>

